TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. IONS
3. SPY
4. NVDA
5. BSX
6. ODFL
7. USO
8. AZN
9. LAD
10. ROIV

Go back to TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer
ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 200,261       

ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 200,261       

Compugen Ltd (NASDAQ: CGEN) Delayed: 2.59 --0 (-0%)
Previous Close $2.59    52 Week High $7.79 
Open $2.59    52 Week Low $4.32 
Day High $2.59    P/E N/A 
Day Low $2.59    EPS $-0.36 
Volume 2,621       

Compugen Ltd (NASDAQ: CGEN) Delayed: 2.59 --0 (-0%)
Previous Close $2.59    52 Week High $7.79 
Open $2.59    52 Week Low $4.32 
Day High $2.59    P/E N/A 
Day Low $2.59    EPS $-0.36 
Volume 2,621       

Daiichi Sankyo Co Limited Sponsored ADR (AMEX: DSNKY) Delayed: 18.01 --0 (-0%)
Previous Close $18.01    52 Week High $26.24 
Open $18.01    52 Week Low $18.86 
Day High $18.01    P/E N/A 
Day Low $18.01    EPS $0.00 
Volume 175